ZimVie separation completed

Zimmer Biomet’s spine and dental spinoff, ZimVie, completed its separation on schedule March 1.

Advertisement

The March 1 separation date was given in February alongside Zimmer Biomet’s fourth quarter results. ZimVie shares will begin trading on the Nasdaq under the symbol “ZIMV,” according to a March 1 news release.

Vafa Jamali, who previously worked at Medtronic, leads ZimVie as CEO. The independent spinoff company was first announced in February 2021.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.